Stem Cells Research: Market Research Report
This report analyzes the US Market for Stem Cells Research in US$ Million.
Annual forecasts are provided for the period 2006 through 2015.
The report profiles 92 companies including many key and niche players such as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cryo-Cell International, Inc., Cytori Therapeutics, Inc., Edstrom Biosciences, Inc., Geron Corporation, International Stem Cell Corporation, Neuralstem, Inc., NeuroGeneration, Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Annual forecasts are provided for the period 2006 through 2015.
The report profiles 92 companies including many key and niche players such as Advanced Cell Technology, Inc., Athersys, Inc., BioE, Inc., Cryo-Cell International, Inc., Cytori Therapeutics, Inc., Edstrom Biosciences, Inc., Geron Corporation, International Stem Cell Corporation, Neuralstem, Inc., NeuroGeneration, Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
1.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITION
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Types of Stem Cells
Embryonic Stem Cells
Adult Stem Cells
2.MARKET OVERVIEW
Overview
Major Achievements Thus Far
Stem Cell Therapy Gaining Acceptance
New Growth Areas
Orthopedic Products – A potential growth sector
Utilitarian Functions of Cord Blood Stem Cells
Umbilical Cord Stem Cells in the Treatment of Hepatic Diseases
Human Umbilical Cord Blood-Derived Stem Cells to Synthesize Insulin
Challenges
Stem Cell Research And the Ethical Angle
3.MARKET DYNAMICS AND TRENDS
North America Dominates Global Stem Cells Market
Stem Cells Breakthrough Reshaping the Area of Medicine
New Technologies Draw Significant Attention
Ethical Issues and Nascent Stage – Key Market Restraints for Stem Cells
Medical Tourism Picks Up in Stem Cell Therapy
Government Regulations Fail to Prevent Medical Tourism in Stem Cell Therapy
US and Japan Surge Ahead of Europe in Stem Cell Patents
4.STEM CELLS MARKET DYNAMICS – BY TYPE
Adult Stem Cells Hold Tremendous Potential
A Low Risk Investment
Adult Stem Cells Garner More Investments for Research
Low Versatility - A Major Limiting Factor for Adult Stem Cells
Hematopoietic Stem Cells – Enjoying Enduring Success
The Restraining Factors
Mesenchymal Stem Cells – A Promising Therapeutic Option
Difficulty in Isolation and Lower Understanding Hampers Growth
Induced Pluripotent Stem Cells – An Alternative to ESCs
A Peek Into the Discovery of iPS
Drug Development – A Major Application for iPS
Regenerative Medicine
Establishing iPS Cell Banks
Intractable and Congenital Disease Treatments
Repairing Organs
Embryonic Stem Cells to Transfigure the Field of Medicine
Lack of Safety and Efficacy Data Remains A Concern
5.STEM CELLS RESEARCH BY APPLICATION
Stem Cells in Disease Management
Stem Cell Therapy in Regenerative Medicine
Stem Cell Therapy – A Promising Treatment for Neurological Disorders
Large-Scale Studies Imperative to Substantiate Early Positive Results In Cardiovascular Diseases
Stem Cell Therapy in Cancer
Stem Cells Set Foot in Personal Care
Aging Population to Drive Orthopedic Stem Cell Market
Other Diseases
Stem Cells in Drug Discovery
Tools for Drug Development
6.REGULATORY ENVIRONMENT
Laws Governing Stem Cells Research – The Divided World
Laws and Regulations in Stem Cells Research in Select Countries
7.PRODUCT OVERVIEW
Stem Cell Research
Stem Cells – Description
Types of Stem Cells
Embryonic Stem Cells
mES and hES
R-NSCs
Adult Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Umbilical Cord Stem Cells
Neuronal Stem Cells
Dental Stem Cells
Pluripotent Adult Stem Cells
Other Key Cell Types
The Stem Cell Line – Cell Division
Stem Cells – Properties
Ability to Renew on its Own
Potency
Definitions of Various Potencies
Identification of Stem Cells
Stem Cells – Applications
History of Stem Cells
Stem Cells – Services and Products
Significance of Stem Cell Products/Services
8.RESEARCH BREAKTHROUGHS
Parthenogenetic Stem Cells Holds Potential in the Treatment of Thalassemia
hESCs - A Potential Source for Unlimited Supply of Functional Platelets
Sperm-Producing Stem Cells For Diabetes Treatment – Researchers Explore Prospects
Cellonis Achieves Outstanding Results of Its Stem Cell Therapy for Diabetes
Stem Cells From Fallopian Tubes – A Prospective New Source
Stem Cells from Fat – Enhancing Stem Cells Accessibility
Skin Cells to Stem Cells – A New Promising Method
Stem Cells to Repair Brain Damage After A Stroke
ACT Shows hESCs’ Potential to Become An Unlimited Source for Functional RBCs
9.PRODUCT INNOVATIONS/INTRODUCTIONS
StemCells Launches New Antibody Reagents
Arteriocyte Introduces Nanex Hematopoietic Stem Cell Expansion Kit
Vitrolife Unveils Growth Factors and Cytokines for Stem Cell Cultivation
BioTime to Introduce New Product Line of Stem Cell Products
Chemaphor Introduces Stem Cell Regenerative Therapy
Stempeutics Research Malaysia to Launch Ischemic CS Therapy
Vitro Diagnostics Launches Novel Serum-free Stem Cell Growth Medium
ThermoGenesis to Launch Res-Q System
Invitrogen to Introduce New Technology for Safe Stem Cell Treatment
Millipore Unveils MilliTrace™ Stem Cell Lines
Millipore Unveils ESGRO Complete™ PLUS medium
Bayer Launches Reformulated Liquid Leukine®
Shenzhen Beike Biotechnology and CMC Launch NBPD's SCRM Industrial Project
Vitro Unveils New Products Supporting Stem Cell Research
Endogenous Stem Cells Activators Introduces KRONOS IV
ArunA Biomedical and Open Biosystems Launch iPS Kit
Invitrogen Introduces Neon Transfection Device
Invitrogen Introduces Xenogeneic-Free Media
NanoInk Unveils NanoStem Cell Division
Advanced Cell Technology Unveils New Process for Functional Hepatocytes Generation
10.RECENT INDUSTRY ACTIVITY
NeoStem Merges with Progenitor Cell Therapy
EHS Enters into Joint Venture with Celulas Genetica
RJ to Form New Subsidiary
NuPotential and VistaGen Receive NIH Grant for Development of iPS Cells (US)
BioCells Argentina Launches Dental Pulp Stem Cells Storage Program
EHSI Forges Option Deal with OceanBASIS
EHSI and Regenetech Ink License Agreement
Transposagen Biopharmaceuticals and CDI Ink Non-exclusive License Agreement
Kiadis Signs Licensing Agreement with Hospira to Develop and Market Hematology Product
ACT Obtains FDA Approval for Human Clinical Trials of hESCs for Dry AMD
OncoMed Commences Phase I Clinical Trial of OMP-59R5
Advanced Cell Technology and Roslin Cells Ink MoU
Mesoblast Takes Over Angioblast
Power3 Medical Products and Rozetta-Cell Life Sciences to Merge
University of California and BioTime Ink Material Transfer Agreement
ISCO And John Mauldin Commence Marketing Alliance for Skincare Products
Cord Blood America Inks Letter of Intent to Take Over Cryo-Cell Mexico
Mesoblast Enters into Stem Cell Marketing Deal with US Company
Bayer HealthCare Enters into Alliance with OncoMed Pharmaceuticals
SiriCell Technologies Acquires Remaining Stake in International Stem Cell JV
StemCells Receives Swissmedic Approval for Neural Stem Cells Trial In Chronic Spinal Cord Injury
ACT Obtains FDA Clearance for Human Clinical Trials of hESCs for SMD
ReNeuron Treats First Patient in Stem Cell Therapy Clinical Trial for Stroke
Amedica/US Spine Inks a Licensing and Distribution Agreement with BioDlogics
Vet-Stem Inks Sub-Licence Agreement with Australian Veterinary Stem Cells
Athersys Obtains FDA Approval for Phase II Trial for IBD Using MultiStem®
Stemedica and AnC Form Stem Cells JV
Fate Therapeutics Enters into Collaboration and Licensing Agreement with BD
BrainStorm Obtains Clearance for Stem Cell Therapy Clinical Trial for ALS in Israel
Shrink Nanotechnologies Enters Final Stage of StemDisc Commercialization
Cryo-Cell’s License Partner S-Evans Biosciences Opens New Laboratory
Geron Receives FDA Approval to Initiate Clinical Trials of hESCs for Treating Acute Spinal Cord Injuries
Cytori Therapeutics' Celution System Obtains European Approval
TGA Grants Approval to Mesoblast to Supply MPC Products
BioTime Inks Partnership with Hadasit Bio to Take over ES Cell International
AssureImmune and Banco Merge
Salk Institute to Use Cyntellect’s Cell Processing Workstation LEAP™
STEMCELL Inks Agreement with Stanford University for Virus Free Technique
NeoStem Inks Partnership Agreement with Catholic Church
Stemgent Signs Deal with Miltenyi to Co-develop and Market Stem Cell Research Products
BioTime Acquires ES Cell International
Cipla Enters into Partnership with Stempeutics to Enter Stem Cell Segment
Vitro Diagnostics Signs Contract with HemoGenix
Fate Acquires Verio Therapeutics
Vitrolife Inks Licensing Agreement with Finn-Medi Research
AXM Pharma to Establish Stem Cell Plant
Stem Cell Therapy Merges with Histostem
Cord Blood America Enters into Contract with BioE for Cord Blood Processing System
Pfizer Acquires Rights to Athersys’ Stem Cell Therapy
Enterprise Investors Acquires Large Interest in PBKM
Fate Therapeutics to Distribute Stem Cell Products through Becton Dickinson
NHMC Merges with BioStem Genetics
Riverside Acquires Crioestaminal
Cryo-Cell International Signs Distribution Agreement with S-Evans Biosciences
Jordanian Stem Cell Purchases Stemedica International’s Stem Cell Technology
BrainStorm Enters into Agreement with Protein Production Services
Novartis Acquires Opexa’s Stem Cell Technology
ThermoGenesis Expands Alliance with Celling Technologies
Bioheart to Test MyoCell SDF-1 in REGEN Trial
Osiris Initiates Enrolment for Prochymal Phase II Clinical Trial for Type I Diabetes Treatment
Stirling Divests Interest in Australian Stem Cell Healthcare
iZumi Bio Merges with Pierian
iZumi Collaborates with CiRA to Expand iPSC Technology
Novartis Forges Research and Development Partnership Agreement with Epistem
Healthcare of Today Acquires Regenetech
Neuralstem and China Medical University to Co-develop Treatment for Stem Cell Stroke
Cytori Inks Agreement with GE Healthcare for StemSource®Technology Commercialization
MedCell Bioscience Merges with NovaThera
StemCells Acquires Stem Cell Sciences
BioSante Pharmaceuticals Merges with Cell Genesys
Cell Therapeutics Enters into Joint Venture with Spectrum Pharmaceuticals
Cryo-Cell International Enters into Collaboration with Cryopraxis Cryobiology
Embryome Sciences Signs Partnership Agreement with Reproductive Genetics Institute
ENKAM Inks Licensing Agreement with STEMCELL
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix
ThermoGenesis and Celling Technologies Extend Collaboration
Vivalis Enters into Collaboration with SAFC Biosciences
ReNeuron Enters into Agreement with Angel Biotechnology Holdings
Cellartis Signs Agreement with ReproCELL
Cellartis and AstraZeneca Extend Collaboration
Embryome Sciences and Millipore Sign Co-Marketing Agreement
Cytori Enters into Partnership with GE Healthcare
Stemgent Enters into Co-Exclusive Marketing Agreement with CellDesign
MultiCell Technologies and Maxim Biotech Sign R&D Agreement
GE Healthcare Collaborates with Geron Corporation
Moraga Biotechnology Licenses BLSCs to Pharmacells
CordLife Develops Stem Cell Therapies in India
NsGene Receives European Patent Rights
Pfizer to Invest in Stem Cell Research
SCTI Commences Histostem Products Distribution Process
Geron Secures FDA Approval for Human Trial of Embryonic Stem Cell-Based Therapy
BioE Obtains FDA Marketing Approval for PrepaCyte-CB
StemCells Obtains FDA Approval for Phase I Clinical Trial of HuCNS-SC® Cells in Treatment of PMD
Athersys Obtains IND for Using Multistem in Treating Ischemic Stroke
Athersys Presents Initial Dosing Data of MultiStem® Phase I Trial in AMI
ACT Creates Five Lines of hESCs Without Embryo Destruction
BioE Inks Agreement with StemSoft
ACT’s Technology Generates 140 Cell Types from hESC
ACT Develops Process for Generating Functional Hepatocytes from hESCs
Applied Biosystems Merges with Invitrogen
Bennett, Coleman and Co Acquires Stake in Stem One Biologicals
BMXP Holdings Acquires Freedom Environmental Services
Saints Capital Completes Neuronyx Acquisition
Intercity Acquires Exordia
iPS and Stem Cell Merge with CDI Merge
Biohellenika Acquires Exclusive Rights of Cytori's StemSource Cell Bank
International Stem Cell Signs Agreement with Millipore Corporation
ReNeuron Enters into Agreement with Angel Biotechnology
ThermoGenesis and Celling Technologies Ink a Distribution Agreement
BioTime and Embryome Ink a Deal with International Stem Cell
Cryo-Cell Enters into Agreement with Saneron
Genzyme Enters into Alliance with Osiris
VivoMedica Enters into Collaboration with Cellartis
Histostem Signs MOU with Stem Cell Therapy
Vantus Inks Agreement with US Davis Center for Equine Health
Stem Cell Sciences Enters into Agreement with Pfizer
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix
Cellartis Signs Agreement with Pfizer
Ortec Changes Corporate Name to Forticell Bioscience
FDA Grants Approval to Genzyme's Mozobil
Pfizer Inaugurates Pfizer Regenerative Medicine Research Facility
Stem Cell Therapeutics Receives Australian Patent
STEMCELL Technologies Secures License Rights to Geron IP
BioTime Starts Embryonic Stem Cell Solution Facility
Geron Successfully Transplants Pancreatic Islet-Like Clusters
StemCells Secures US Patent
PerkinElmer Takes Over ViaCell
Athersys’ MultiStem® Receives US FDA Nod for Phase I Trial in BMT Support and AMI
BioE Teams Up with Phillips Plastics for Stem Cell Therapeutics
11.FOCUS ON SELECT GLOBAL PLAYERS
Advanced Cell Technology, Inc. (US)
Athersys, Inc. (US)
BioE, Inc. (US)
Cellartis AB (Sweden)
Cryo-Cell International, Inc. (US)
Cytori Therapeutics, Inc. (US)
ES Cell International (Singapore)
Gamida Cell Ltd. (Israel)
Genzyme Corporation (US)
Geron Corporation (US)
International Stem Cell Corporation (US)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (US)
NeuroGeneration, Inc. (US)
Osiris Therapeutics, Inc. (US)
StemCells, Inc. (US)
ThermoGenesis Corp. (US)
ViaCord, LLC (US)
12.GLOBAL MARKET PERSPECTIVE
13.THE UNITED STATES
A. MARKET ANALYSIS
North America – Spearheading Global Stem Cells Market
US – The Market Leader for Stem Cell Research Worldwide
Interest in Adult Stem Cell Research Continues
Cosmetic Enhancements Ahead of Therapies for Diseases
Embryonic Stem Cell Research in the US Held Back by Lack of Federal Funding
Vacillating US Policy on Federal Funding for hESC Research
US Revokes Ban On Federal Funding for hESC Research
Federal Funding Remains the Key for Further Progress in the Sector
US Court’s Decree to Block Federal Funding for hESC Research to Affect Biotech Industry
Competitive Scenario
B. MARKET ANALYTICS
14.EUROPE
A. MARKET ANALYSIS
The UK Policy on hESC Remains In Favor of Developing the Science
UK Adopts Practical Approach In Addressing Moral Issues
UK- The First Country to Allow Therapeutic Cloning
B. MARKET ANALYTICS
15.REST OF WORLD
A. MARKET ANALYSIS
The Rise of Asia in Stem Cells Research
US Ban on Federal Funds for hESC Research Boosts Asian Presence
Emergence of China in the Global Stem Cell Research Space
The Indian Stem Cell Research Market – An Overview
B. MARKET ANALYTICS
Total Companies Profiled: 90 (including Divisions/Subsidiaries - 97)
Region/CountryPlayers
The United States 67
Canada
Japan
Europe
France
The United Kingdom
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Middle-East
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Types of Stem Cells
Embryonic Stem Cells
Adult Stem Cells
2.MARKET OVERVIEW
Overview
Major Achievements Thus Far
Stem Cell Therapy Gaining Acceptance
New Growth Areas
Orthopedic Products – A potential growth sector
Utilitarian Functions of Cord Blood Stem Cells
Umbilical Cord Stem Cells in the Treatment of Hepatic Diseases
Human Umbilical Cord Blood-Derived Stem Cells to Synthesize Insulin
Challenges
Stem Cell Research And the Ethical Angle
3.MARKET DYNAMICS AND TRENDS
North America Dominates Global Stem Cells Market
Stem Cells Breakthrough Reshaping the Area of Medicine
New Technologies Draw Significant Attention
Ethical Issues and Nascent Stage – Key Market Restraints for Stem Cells
Medical Tourism Picks Up in Stem Cell Therapy
Government Regulations Fail to Prevent Medical Tourism in Stem Cell Therapy
US and Japan Surge Ahead of Europe in Stem Cell Patents
Table 1. Global Stem Cells Patent Analysis By Market (2008): Percentage Breakdown of Number of Patents Issued for US, Japan and Europe (includes corresponding Graph/Chart)
Table 2. Global Stem Cells Patent Analysis By Product (2008): Percentage Breakdown of Number of Patents Issued for Adult Stem Cells, Human Embryonic Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Neuronal Stem Cells and Others (includes corresponding Graph/Chart)
Table 3. Leading Stem Cell Companies by Patents (2008): Percentage Breakdown of Number of Patents Secured for Geron Corp., Osiris Therapeutics, Olympus Corporation, Wisconsin Alumni Research Foundation, Kourion Therapeutics AG, Japan Science & Tech Agency and Others (includes corresponding Graph/Chart)
4.STEM CELLS MARKET DYNAMICS – BY TYPE
Adult Stem Cells Hold Tremendous Potential
A Low Risk Investment
Adult Stem Cells Garner More Investments for Research
Low Versatility - A Major Limiting Factor for Adult Stem Cells
Hematopoietic Stem Cells – Enjoying Enduring Success
The Restraining Factors
Mesenchymal Stem Cells – A Promising Therapeutic Option
Difficulty in Isolation and Lower Understanding Hampers Growth
Induced Pluripotent Stem Cells – An Alternative to ESCs
A Peek Into the Discovery of iPS
Drug Development – A Major Application for iPS
Regenerative Medicine
Establishing iPS Cell Banks
Intractable and Congenital Disease Treatments
Repairing Organs
Embryonic Stem Cells to Transfigure the Field of Medicine
Lack of Safety and Efficacy Data Remains A Concern
5.STEM CELLS RESEARCH BY APPLICATION
Stem Cells in Disease Management
Stem Cell Therapy in Regenerative Medicine
Stem Cell Therapy – A Promising Treatment for Neurological Disorders
Large-Scale Studies Imperative to Substantiate Early Positive Results In Cardiovascular Diseases
Stem Cell Therapy in Cancer
Stem Cells Set Foot in Personal Care
Aging Population to Drive Orthopedic Stem Cell Market
Other Diseases
Stem Cells in Drug Discovery
Tools for Drug Development
6.REGULATORY ENVIRONMENT
Laws Governing Stem Cells Research – The Divided World
Laws and Regulations in Stem Cells Research in Select Countries
7.PRODUCT OVERVIEW
Stem Cell Research
Stem Cells – Description
Types of Stem Cells
Embryonic Stem Cells
mES and hES
R-NSCs
Adult Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Umbilical Cord Stem Cells
Neuronal Stem Cells
Dental Stem Cells
Pluripotent Adult Stem Cells
Other Key Cell Types
The Stem Cell Line – Cell Division
Stem Cells – Properties
Ability to Renew on its Own
Potency
Definitions of Various Potencies
Identification of Stem Cells
Stem Cells – Applications
History of Stem Cells
Stem Cells – Services and Products
Significance of Stem Cell Products/Services
8.RESEARCH BREAKTHROUGHS
Parthenogenetic Stem Cells Holds Potential in the Treatment of Thalassemia
hESCs - A Potential Source for Unlimited Supply of Functional Platelets
Sperm-Producing Stem Cells For Diabetes Treatment – Researchers Explore Prospects
Cellonis Achieves Outstanding Results of Its Stem Cell Therapy for Diabetes
Stem Cells From Fallopian Tubes – A Prospective New Source
Stem Cells from Fat – Enhancing Stem Cells Accessibility
Skin Cells to Stem Cells – A New Promising Method
Stem Cells to Repair Brain Damage After A Stroke
ACT Shows hESCs’ Potential to Become An Unlimited Source for Functional RBCs
9.PRODUCT INNOVATIONS/INTRODUCTIONS
StemCells Launches New Antibody Reagents
Arteriocyte Introduces Nanex Hematopoietic Stem Cell Expansion Kit
Vitrolife Unveils Growth Factors and Cytokines for Stem Cell Cultivation
BioTime to Introduce New Product Line of Stem Cell Products
Chemaphor Introduces Stem Cell Regenerative Therapy
Stempeutics Research Malaysia to Launch Ischemic CS Therapy
Vitro Diagnostics Launches Novel Serum-free Stem Cell Growth Medium
ThermoGenesis to Launch Res-Q System
Invitrogen to Introduce New Technology for Safe Stem Cell Treatment
Millipore Unveils MilliTrace™ Stem Cell Lines
Millipore Unveils ESGRO Complete™ PLUS medium
Bayer Launches Reformulated Liquid Leukine®
Shenzhen Beike Biotechnology and CMC Launch NBPD's SCRM Industrial Project
Vitro Unveils New Products Supporting Stem Cell Research
Endogenous Stem Cells Activators Introduces KRONOS IV
ArunA Biomedical and Open Biosystems Launch iPS Kit
Invitrogen Introduces Neon Transfection Device
Invitrogen Introduces Xenogeneic-Free Media
NanoInk Unveils NanoStem Cell Division
Advanced Cell Technology Unveils New Process for Functional Hepatocytes Generation
10.RECENT INDUSTRY ACTIVITY
NeoStem Merges with Progenitor Cell Therapy
EHS Enters into Joint Venture with Celulas Genetica
RJ to Form New Subsidiary
NuPotential and VistaGen Receive NIH Grant for Development of iPS Cells (US)
BioCells Argentina Launches Dental Pulp Stem Cells Storage Program
EHSI Forges Option Deal with OceanBASIS
EHSI and Regenetech Ink License Agreement
Transposagen Biopharmaceuticals and CDI Ink Non-exclusive License Agreement
Kiadis Signs Licensing Agreement with Hospira to Develop and Market Hematology Product
ACT Obtains FDA Approval for Human Clinical Trials of hESCs for Dry AMD
OncoMed Commences Phase I Clinical Trial of OMP-59R5
Advanced Cell Technology and Roslin Cells Ink MoU
Mesoblast Takes Over Angioblast
Power3 Medical Products and Rozetta-Cell Life Sciences to Merge
University of California and BioTime Ink Material Transfer Agreement
ISCO And John Mauldin Commence Marketing Alliance for Skincare Products
Cord Blood America Inks Letter of Intent to Take Over Cryo-Cell Mexico
Mesoblast Enters into Stem Cell Marketing Deal with US Company
Bayer HealthCare Enters into Alliance with OncoMed Pharmaceuticals
SiriCell Technologies Acquires Remaining Stake in International Stem Cell JV
StemCells Receives Swissmedic Approval for Neural Stem Cells Trial In Chronic Spinal Cord Injury
ACT Obtains FDA Clearance for Human Clinical Trials of hESCs for SMD
ReNeuron Treats First Patient in Stem Cell Therapy Clinical Trial for Stroke
Amedica/US Spine Inks a Licensing and Distribution Agreement with BioDlogics
Vet-Stem Inks Sub-Licence Agreement with Australian Veterinary Stem Cells
Athersys Obtains FDA Approval for Phase II Trial for IBD Using MultiStem®
Stemedica and AnC Form Stem Cells JV
Fate Therapeutics Enters into Collaboration and Licensing Agreement with BD
BrainStorm Obtains Clearance for Stem Cell Therapy Clinical Trial for ALS in Israel
Shrink Nanotechnologies Enters Final Stage of StemDisc Commercialization
Cryo-Cell’s License Partner S-Evans Biosciences Opens New Laboratory
Geron Receives FDA Approval to Initiate Clinical Trials of hESCs for Treating Acute Spinal Cord Injuries
Cytori Therapeutics' Celution System Obtains European Approval
TGA Grants Approval to Mesoblast to Supply MPC Products
BioTime Inks Partnership with Hadasit Bio to Take over ES Cell International
AssureImmune and Banco Merge
Salk Institute to Use Cyntellect’s Cell Processing Workstation LEAP™
STEMCELL Inks Agreement with Stanford University for Virus Free Technique
NeoStem Inks Partnership Agreement with Catholic Church
Stemgent Signs Deal with Miltenyi to Co-develop and Market Stem Cell Research Products
BioTime Acquires ES Cell International
Cipla Enters into Partnership with Stempeutics to Enter Stem Cell Segment
Vitro Diagnostics Signs Contract with HemoGenix
Fate Acquires Verio Therapeutics
Vitrolife Inks Licensing Agreement with Finn-Medi Research
AXM Pharma to Establish Stem Cell Plant
Stem Cell Therapy Merges with Histostem
Cord Blood America Enters into Contract with BioE for Cord Blood Processing System
Pfizer Acquires Rights to Athersys’ Stem Cell Therapy
Enterprise Investors Acquires Large Interest in PBKM
Fate Therapeutics to Distribute Stem Cell Products through Becton Dickinson
NHMC Merges with BioStem Genetics
Riverside Acquires Crioestaminal
Cryo-Cell International Signs Distribution Agreement with S-Evans Biosciences
Jordanian Stem Cell Purchases Stemedica International’s Stem Cell Technology
BrainStorm Enters into Agreement with Protein Production Services
Novartis Acquires Opexa’s Stem Cell Technology
ThermoGenesis Expands Alliance with Celling Technologies
Bioheart to Test MyoCell SDF-1 in REGEN Trial
Osiris Initiates Enrolment for Prochymal Phase II Clinical Trial for Type I Diabetes Treatment
Stirling Divests Interest in Australian Stem Cell Healthcare
iZumi Bio Merges with Pierian
iZumi Collaborates with CiRA to Expand iPSC Technology
Novartis Forges Research and Development Partnership Agreement with Epistem
Healthcare of Today Acquires Regenetech
Neuralstem and China Medical University to Co-develop Treatment for Stem Cell Stroke
Cytori Inks Agreement with GE Healthcare for StemSource®Technology Commercialization
MedCell Bioscience Merges with NovaThera
StemCells Acquires Stem Cell Sciences
BioSante Pharmaceuticals Merges with Cell Genesys
Cell Therapeutics Enters into Joint Venture with Spectrum Pharmaceuticals
Cryo-Cell International Enters into Collaboration with Cryopraxis Cryobiology
Embryome Sciences Signs Partnership Agreement with Reproductive Genetics Institute
ENKAM Inks Licensing Agreement with STEMCELL
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix
ThermoGenesis and Celling Technologies Extend Collaboration
Vivalis Enters into Collaboration with SAFC Biosciences
ReNeuron Enters into Agreement with Angel Biotechnology Holdings
Cellartis Signs Agreement with ReproCELL
Cellartis and AstraZeneca Extend Collaboration
Embryome Sciences and Millipore Sign Co-Marketing Agreement
Cytori Enters into Partnership with GE Healthcare
Stemgent Enters into Co-Exclusive Marketing Agreement with CellDesign
MultiCell Technologies and Maxim Biotech Sign R&D Agreement
GE Healthcare Collaborates with Geron Corporation
Moraga Biotechnology Licenses BLSCs to Pharmacells
CordLife Develops Stem Cell Therapies in India
NsGene Receives European Patent Rights
Pfizer to Invest in Stem Cell Research
SCTI Commences Histostem Products Distribution Process
Geron Secures FDA Approval for Human Trial of Embryonic Stem Cell-Based Therapy
BioE Obtains FDA Marketing Approval for PrepaCyte-CB
StemCells Obtains FDA Approval for Phase I Clinical Trial of HuCNS-SC® Cells in Treatment of PMD
Athersys Obtains IND for Using Multistem in Treating Ischemic Stroke
Athersys Presents Initial Dosing Data of MultiStem® Phase I Trial in AMI
ACT Creates Five Lines of hESCs Without Embryo Destruction
BioE Inks Agreement with StemSoft
ACT’s Technology Generates 140 Cell Types from hESC
ACT Develops Process for Generating Functional Hepatocytes from hESCs
Applied Biosystems Merges with Invitrogen
Bennett, Coleman and Co Acquires Stake in Stem One Biologicals
BMXP Holdings Acquires Freedom Environmental Services
Saints Capital Completes Neuronyx Acquisition
Intercity Acquires Exordia
iPS and Stem Cell Merge with CDI Merge
Biohellenika Acquires Exclusive Rights of Cytori's StemSource Cell Bank
International Stem Cell Signs Agreement with Millipore Corporation
ReNeuron Enters into Agreement with Angel Biotechnology
ThermoGenesis and Celling Technologies Ink a Distribution Agreement
BioTime and Embryome Ink a Deal with International Stem Cell
Cryo-Cell Enters into Agreement with Saneron
Genzyme Enters into Alliance with Osiris
VivoMedica Enters into Collaboration with Cellartis
Histostem Signs MOU with Stem Cell Therapy
Vantus Inks Agreement with US Davis Center for Equine Health
Stem Cell Sciences Enters into Agreement with Pfizer
Sigma-Aldrich Inks Distribution Agreement with AlphaGenix
Cellartis Signs Agreement with Pfizer
Ortec Changes Corporate Name to Forticell Bioscience
FDA Grants Approval to Genzyme's Mozobil
Pfizer Inaugurates Pfizer Regenerative Medicine Research Facility
Stem Cell Therapeutics Receives Australian Patent
STEMCELL Technologies Secures License Rights to Geron IP
BioTime Starts Embryonic Stem Cell Solution Facility
Geron Successfully Transplants Pancreatic Islet-Like Clusters
StemCells Secures US Patent
PerkinElmer Takes Over ViaCell
Athersys’ MultiStem® Receives US FDA Nod for Phase I Trial in BMT Support and AMI
BioE Teams Up with Phillips Plastics for Stem Cell Therapeutics
11.FOCUS ON SELECT GLOBAL PLAYERS
Advanced Cell Technology, Inc. (US)
Athersys, Inc. (US)
BioE, Inc. (US)
Cellartis AB (Sweden)
Cryo-Cell International, Inc. (US)
Cytori Therapeutics, Inc. (US)
ES Cell International (Singapore)
Gamida Cell Ltd. (Israel)
Genzyme Corporation (US)
Geron Corporation (US)
International Stem Cell Corporation (US)
Mesoblast Ltd. (Australia)
Neuralstem, Inc. (US)
NeuroGeneration, Inc. (US)
Osiris Therapeutics, Inc. (US)
StemCells, Inc. (US)
ThermoGenesis Corp. (US)
ViaCord, LLC (US)
12.GLOBAL MARKET PERSPECTIVE
Table 4. Global Recent Past, Current & Future Analysis of Adult Stem Cell Research By Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Investment Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 5. World 10-Year Perspective for Adult Stem Cell Research by Geographic Region – Percentage Breakdown of Annual Investments for US, Europe and Rest of World Markets for Years 2006, 2010 & 2015 (includes corresponding Graph/Chart)
13.THE UNITED STATES
A. MARKET ANALYSIS
North America – Spearheading Global Stem Cells Market
US – The Market Leader for Stem Cell Research Worldwide
Interest in Adult Stem Cell Research Continues
Cosmetic Enhancements Ahead of Therapies for Diseases
Embryonic Stem Cell Research in the US Held Back by Lack of Federal Funding
Vacillating US Policy on Federal Funding for hESC Research
US Revokes Ban On Federal Funding for hESC Research
Federal Funding Remains the Key for Further Progress in the Sector
US Court’s Decree to Block Federal Funding for hESC Research to Affect Biotech Industry
Competitive Scenario
Table 6. Leading Players in the US Stem Cell Therapeutics Market (2007): Percentage Breakdown of Value Sales for ViaCell Inc., Cryo-Cell, Osiris Therapeutics Inc., International Stem Cell Corporation, Geron Corp., Cytori Therapeutics Inc., Athersys Inc., and Others (includes corresponding Graph/Chart)
B. MARKET ANALYTICS
Table 7. US Recent Past, Current & Future Analysis of Adult Stem Cell Research Market Analyzed with Annual Investment Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
14.EUROPE
A. MARKET ANALYSIS
The UK Policy on hESC Remains In Favor of Developing the Science
UK Adopts Practical Approach In Addressing Moral Issues
UK- The First Country to Allow Therapeutic Cloning
B. MARKET ANALYTICS
Table 8. European Recent Past, Current & Future Analysis of Adult Stem Cell Research Market Analyzed with Annual Investment Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
15.REST OF WORLD
A. MARKET ANALYSIS
The Rise of Asia in Stem Cells Research
US Ban on Federal Funds for hESC Research Boosts Asian Presence
Emergence of China in the Global Stem Cell Research Space
The Indian Stem Cell Research Market – An Overview
B. MARKET ANALYTICS
Table 9. Rest of World Recent Past, Current & Future Analysis of Adult Stem Cell Research Market Analyzed with Annual Investment Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Total Companies Profiled: 90 (including Divisions/Subsidiaries - 97)
Region/CountryPlayers
The United States 67
Canada
Japan
Europe
France
The United Kingdom
Spain
Rest of Europe
Asia-Pacific (Excluding Japan)
Latin America
Middle-East
